ERAS program expedites recovery for congenital heart surgery patients
Anxiety grows as long-term care awaits COVID-19 vaccines
31 January 2021Patient-reported outcomes from the randomized phase III CROWN study of first-line Lorlatinib versus in ALK+ NSCLC
31 January 2021ERAS program expedites recovery for congenital heart surgery patients
Select patients born with heart defects and who undergo congenital heart surgery recover with few complications and reduced opioid use when a comprehensive, evidence-based enhanced recovery after surgery (ERAS) program is used, according to research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons.
